Amendment: SEC Form SCHEDULE 13G/A filed by Bicara Therapeutics Inc.
SCHEDULE 13G/A - Bicara Therapeutics Inc. (0002023658) (Subject)
Live Feed
Delayed 3mPress · Analyst · Buys · SEC · FDA · Financials
Signed out · 3-min delay · Sign up for real-time
- Amendment: SEC Form SCHEDULE 13G/A filed by Janus Henderson Group plc
SCHEDULE 13G/A - Janus Henderson Group Ltd. (0001274173) (Filed by)
- Amendment: SEC Form SCHEDULE 13G/A filed by Janux Therapeutics Inc.
SCHEDULE 13G/A - Janux Therapeutics, Inc. (0001817713) (Subject)
- Amendment: SEC Form SCHEDULE 13G/A filed by Janus Henderson Group plc
SCHEDULE 13G/A - Janus Henderson Group Ltd. (0001274173) (Filed by)
- Amendment: SEC Form SCHEDULE 13G/A filed by Ocugen Inc.
SCHEDULE 13G/A - Ocugen, Inc. (0001372299) (Subject)
- SEC Form 6-K filed by Bragg Gaming Group Inc.
6-K - Bragg Gaming Group Inc. (0001867834) (Filer)
- SEC Form 144 filed by American Strategic Investment Co.
144 - American Strategic Investment Co. (0001595527) (Subject)
- SEC Form SCHEDULE 13G filed by Revolution Medicines Inc.
SCHEDULE 13G - Revolution Medicines, Inc. (0001628171) (Subject)
- SEC Form SCHEDULE 13G filed by Janus Henderson Group plc
SCHEDULE 13G - Janus Henderson Group Ltd. (0001274173) (Filed by)
- SEC Form SCHEDULE 13G filed by Inspired Entertainment Inc.
SCHEDULE 13G - Inspired Entertainment, Inc. (0001615063) (Subject)
- SEC Form SCHEDULE 13G filed by JATT II Acquisition Corp
SCHEDULE 13G - JATT II Acquisition Corp. (0002112446) (Subject)
- SEC Form SCHEDULE 13G filed by LPL Financial Holdings Inc.
SCHEDULE 13G - LPL Financial Holdings Inc. (0001397911) (Subject)
- SEC Form SCHEDULE 13G filed by Janus Henderson Group plc
SCHEDULE 13G - Janus Henderson Group Ltd. (0001274173) (Filed by)
- Amendment: SEC Form SCHEDULE 13G/A filed by Lionheart Holdings
SCHEDULE 13G/A - Lionheart Holdings (0002015955) (Subject)
- SEC Form 13F-HR filed by Franklin Resources Inc.
13F-HR - FRANKLIN RESOURCES INC (0000038777) (Filer)
- Corporación América Airports Announces Second Quarter 2026 Financial Results Call and Webcast
Corporación América Airports S.A. (NYSE:CAAP), one of the leading private airport operators in the world, today announced that it will report its Second Quarter 2026 results on Tuesday, August 18, before market opens. We remind all participants to connect through the telephone in order to ask questions. Earnings Release Tuesday, August 18, 2026 Time: Before Market Opens Conference Call Tuesday, August 18, 2026 Time: 12:00pm Eastern Time Executives Mr. Martín Eurnekian, Chief Executive Officer Mr. Jorge Arruda, Chief Financial Officer Mr. Patricio Iñaki Esnaola, Head of Investor Relations To participate, please dial in 1-833-461-5787 (US, Toll Free) +44-808-196-8935 (UK, Toll Free) C
- SEC Form SCHEDULE 13G filed by Bluejay Diagnostics Inc.
SCHEDULE 13G - Bluejay Diagnostics, Inc. (0001704287) (Subject)
- SEC Form 6-K filed by Blue Moon Metals Inc.
6-K - Blue Moon Metals Inc. (0001732379) (Filer)
- Today's Stocks in the News
DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The small-cap market is heating up as earnings acceleration, AI adoption, defense technology and government opportunities create a fresh wave of catalysts. CorMedix Therapeutics: DefenCath Keeps the Cash Flow Story Accelerating CorMedix Therapeutics (NASDAQ:CRMD) is entering the second half of 2026 with increasingly powerful commercial momentum. The company reported $101.9 million in second-quarter consolidated revenue, including $66.1 million from DefenCath and $35.8 million from its acquired Melinta portfolio. Net income reached $26.0 million, while adjusted EBITDA surged to $58.7 million. CorMedix also finished June with $256.7 million in cash